| 缩写名/全名 |
CLIN COLORECTAL CANC
Clinical Colorectal Cancer |
||||||||||||||||||||
| ISSN号 | 1533-0028 | ||||||||||||||||||||
| 研究方向 | 医学-肿瘤学 | ||||||||||||||||||||
| 影响因子 | 2015:3.09, 2016:4.507, 2017:3.861, 2018:3.176, 2019:3.245, | ||||||||||||||||||||
| 出版国家 | UNITED STATES | ||||||||||||||||||||
| 出版周期 | Bimonthly | ||||||||||||||||||||
| 年文章数 | 78 | ||||||||||||||||||||
| 出版年份 | 2001 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | >12周，或约稿 |
||||||||||||||||||||
| 录用比例 | 较易 | ||||||||||||||||||||
| 投稿链接 | http://ees.elsevier.com/ccrc/ | ||||||||||||||||||||
| 投稿官网 | http://www.journals.elsevier.com/clinical-colorectal-cancer/ | ||||||||||||||||||||
| h-index | 45 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1533-0028%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis Author: Yaqi Li, Yang Feng, Weixing Dai, Qingguo Li, Sanjun Cai, Junjie Peng Journal: Clinical Colorectal Cancer, 2018, Vol., , DOI:10.1016/j.clcc.2018.10.005 DOI |
| 2. | Challenges That Hinder the Translation of Clinical Advances Into Practice: Results From an International Assessment in Colorectal Cancer. Author: Lazure P, Marshall JL, Hayes SM, Murray S. Journal: Clin Colorectal Cancer. 2016 Mar;15(1):54-66. doi: 10.1016/j.clcc.2015.07.006. Epub 2015 Jul 29. PubMed |
| 3. | Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Years. Author: Wang L, Li YH, Cai Y, Zhan TC, Gu J. Journal: Clin Colorectal Cancer. 2016 Jun;15(2):152-7. doi: 10.1016/j.clcc.2015.10.001. Epub 2015 Oct 22. PubMed |
| 4. | Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin. Author: Cohen SA, Wu C, Yu M, Gourgioti G, Wirtz R, Raptou G, Gkakou C, Kotoula V, Pentheroudakis G, Papaxoinis G, Karavasilis V, Pectasides D, Kalogeras KT, Fountzilas G, Grady WM. Journal: Clin Colorectal Cancer. 2016 Jun;15(2):164-9. doi: 10.1016/j.clcc.2015.10.005. Epub 2015 Nov 11. PubMed |
| 5. | Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial. Author: Zhao H, Wang Y, Yu J, Wei F, Cao S, Zhang X, Dong N, Li H, Ren X. Journal: Clin Colorectal Cancer. 2016 Feb 16. pii: S1533-0028(16)30017-2. doi: 10.1016/j.clcc.2016.02.005. [Epub ahead of print] PubMed |
| 6. | Outcome of Molecular Targeted Agents Plus Chemotherapy for Second-Line Therapy of Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Trials. Author: Pei X, Liu Y, Sun L, Zhang J, Fang Y, Liao X, Liu J, Zhang C, Yin T. Journal: Clin Colorectal Cancer. 2016 Mar 31. pii: S1533-0028(16)30030-5. doi: 10.1016/j.clcc.2016.03.005. [Epub ahead of print] PubMed |
| 7. | Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Author: wanglinmd Journal: Clinical Colorectal Cancer, 2016. |
| 8. | Outcome of Molecular Targeted Agents Plus Chemotherapy for Second-Line Therapy of Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Trials Author: Tiejun Yin Journal: Clinical Colorectal Cancer, 2016. |
| 9. | Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial Author: Xiubao Ren Journal: Clinical Colorectal Cancer, 2016. |
| 10. | Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial Author: Hui Li Journal: Clinical Colorectal Cancer, 2016. |
|
|
